NCT02531568View on ClinicalTrials.gov

Drug Interaction Study of Warfarin and MT-3995

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

August 31, 2015

Study Completion Date

September 30, 2015

Conditions
Healthy
Interventions
DRUG

Warfarin

DRUG

MT-3995

Trial Locations (1)

Unknown

Clinical research organization, Neu-Ulm

Sponsors
All Listed Sponsors
lead

Mitsubishi Tanabe Pharma Corporation

INDUSTRY